# Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer

> **NCT01490749** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 17 (actual)

## Conditions studied

- Esophageal Cancer
- Neoplasms, Esophageal

## Interventions

- **DRUG:** RAD001
- **DRUG:** XELOX
- **DRUG:** Carboplatin
- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT01490749
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490749, "Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01490749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*